Crossmark

A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant

Crossref DOI link: https://doi.org/10.1007/s10875-019-00631-6

Published Online: 2019-05-11

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Kurolap, Alina

Eshach Adiv, Orly

Konnikova, Liza

Werner, Lael

Gonzaga-Jauregui, Claudia

Steinberg, Maya

Mitsialis, Vanessa

Mory, Adi

Nunberg, Moran Y.

Wall, Sarah

Shaoul, Ron

Overton, John D.

Shuldiner, Alan R.

Zohar, Yaniv

Paperna, Tamar

Snapper, Scott B.

Shouval, Dror S.

Baris Feldman, Hagit
Funding

Funding for this research was provided by:

Israel Science Foundation

Jeffrey Modell Foundation

National Institutes of Health (HL59561, DK034854, AI50950)

Leona M. and Harry B. Helmsley Charitable Trust

Wolpow Family Chair in IBD Treatment and Research
License Information

Text and Data Mining valid from 2019-05-01

Version of Record valid from 2019-05-01
More Information

Article History

Received: 16 September 2018

Accepted: 14 April 2019

First Online: 11 May 2019

Compliance with Ethical Standards

: The study was approved by the institutional Helsinki committee, and written informed consent was obtained as customary.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below